Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : A Biotech Bonanza! -- Ignore unavailable to you. Want to Upgrade?

To: Giuseppe Scalamogna who wrote (21)	10/22/1997 4:25:00 PM
From: Tom Jones	Respond to of 64

Here's a tip: ADGI Announces Sales Revenues and Receivables for 3rd Quarter NEW YORK--(BUSINESS WIRE)--Oct. 22, 1997--American Diversified Group (OTC.BB:ADGI) Tuesday announced that for the first time, it shall report sales revenues and accounts receivable for a fiscal quarter. ADGI has orders shipped, prepaid orders, and orders subject to shipping, which total approximately $150,000 as of Sept. 30, 1997, which will be publicly reported and reflected in ADGI's Quarterly Report on Form 10-QSB being filed with the Securities and Exchange Commission. Such results are principally from ADGI's pharmaceutical and medical products operations and secondarily from the recent commencement by ADGI of call-back telecommunication sales in West Africa. ADGI projects that it shall experience a significant increase in sales revenues and accounts receivable from both its pharmaceutical and medical products operations as well as from its telecommunications operations during the last quarter of the fiscal year ended Dec. 31, 1997, which it shall report in its Annual Report on Form 10-KSB. For further information, ADGI is now part of the Broadcast Fax System, which will disseminate ADGI information and is accessible to all ADGI shareholders via fax. Please contact ADGI's NYC Investor Relations and Conference Office at 212/332-5009 to be part of ADGI's fax network.